Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ancona Pharmaceuticals Private Limited is an Indian pharmaceutical manufacturing company based in Roorkee, Uttarakhand. Established in 2023, the company specializes in the production, marketing, and distribution of a diverse range of high-quality generic and branded formulations, including tablets and capsules. Its commercial portfolio features key products such as Lesuprime (levosulpiride), Panzet-L (pantoprazole and levosulpiride), Robnix LS (rabeprazole and levosulpiride), and Doxeprime (doxepin). Operating from an ISO 9001:2015, GMP, and GLP-certified facility, Ancona Pharmaceuticals focuses on therapeutic areas such as gastroenterology, neurology, and psychiatry. The company serves the domestic Indian market through third-party manufacturing services and PCD (Propaganda Cum Distribution) pharma franchise opportunities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ancona.